Skip to main content
. 2022 Nov 12;7:144. doi: 10.1038/s41541-022-00571-0

Fig. 4. Comparison of immune responses between variant vaccine and prorotype vaccine in BALB/c mice.

Fig. 4

A Pseudovirus neutralizing antibody titers (GMT ± 95%CI) against prototype SARS-CoV-2, Beta strain, and Delta strain at day 35. B Results (mean ± SD) of S-specific ELISPOT at day 35. Note: *p < 0.05; ****p < 0.0001.